Loading…

OK to use analytics cookies? We measure usage without cookies either way; accepting lets us see repeat visits. Declining changes nothing about how the site works. Privacy policy

Log in Create a free account

Directory

Every key opinion leader in the directory, every fact cited to its public source.

Showing 49–53 of 53 KOLs

Sort

Drug: Isatuximab✕

Carl Landgren, MD

Enriched profileMyelomaHematology / OncologySoutheast · FL

—
publications: 0
h-index: 9
trials

View profile →

Amrita Krishnan, MD

City of Hope

Enriched profileHematologyHematologyWest · CA

—
publications: 59
h-index: 14
trials

View profile →

Donald Richards, MD

Texas Oncology-Tyler

Enriched profileGastrointestinalMedical OncologySouth Central · TX

—
publications: 0
h-index: 8
trials

View profile →

Ralph Boccia, MD

The Center for Cancer & Blood Disorders

Enriched profileGastrointestinalHematology / OncologyNortheast · MD

—
publications: 39
h-index: 7
trials

View profile →

William Bensinger, MD

Swedish Cancer Institute

Enriched profileMyelomaMedical OncologyWest · WA

—
publications: 64
h-index: 17
trials

View profile →

← PrevPage 3 of 3Next →

FindMyKOL

The world’s largest open source directory of pharma KOLs.

KOLs by therapeutic area

Oncology
Respiratory
Cardiology
Infectious Disease
Neurology
Rare/Genetic
Dermatology
Gastroenterology
Psychiatry
Endocrinology/Metabolic
Rheumatology/Immunology
Nephrology
Ophthalmology
Hematology
Epidemiology
All therapeutic areas →

KOLs by region

Northeast
West
Southeast
Midwest
South Central
All regions →

About

Directory
Top experts by indication
KOL finder
Institutions
Companies
About us
Blog
Pricing
Methodology
Sources
How we verify
Contact

© 2026 FindMyKOL